Acute Myeloid Leukemia in the Elderly Patient: New Strategies

about

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

Item

http://www.wikidata.org/entity/Q38835119

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

@en

type

Item

label

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

@en

prefLabel

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

@en

P1476

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

@en

P2093

Xavier Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.

The hallmarks of aging

Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.

Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry.

Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.

Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome

P304

1-11

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S40487-015-0006-7

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27182475

http://www.w3.org/2001/XMLSchema#string

P932

4837938

http://www.w3.org/2001/XMLSchema#string

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

about

Acute Myeloid Leukemia in the Elderly Patient: New Strategies

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P932